Cargando…
Targeting HDACs: A Promising Therapy for Alzheimer's Disease
Epigenetic modifications like DNA methylation and histone acetylation play an important role in a wide range of brain disorders. Histone deacetylases (HDACs) regulate the homeostasis of histone acetylation. Histone deacetylase inhibitors, which initially were used as anticancer drugs, are recently s...
Autores principales: | Xu, Ke, Dai, Xue-Ling, Huang, Han-Chang, Jiang, Zhao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177096/ https://www.ncbi.nlm.nih.gov/pubmed/21941604 http://dx.doi.org/10.1155/2011/143269 |
Ejemplares similares
-
The promise and perils of HDAC inhibitors in neurodegeneration
por: Didonna, Alessandro, et al.
Publicado: (2015) -
The promise of stem cells in the therapy of Alzheimer’s disease
por: Yue, Chunmei, et al.
Publicado: (2015) -
Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
por: Palamaris, Kostas, et al.
Publicado: (2022) -
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
por: Wu, Linyu, et al.
Publicado: (2022) -
The promise of music therapy for Alzheimer's disease: A review
por: Matziorinis, Anna Maria, et al.
Publicado: (2022)